Literature DB >> 17656071

Antisaccade task performance in patients at ultra high risk for developing psychosis.

Dorien Nieman1, Hiske Becker, Reinaud van de Fliert, Niels Plat, Lo Bour, Hans Koelman, Maria Klaassen, Peter Dingemans, Maurice Niessen, Don Linszen.   

Abstract

Patients with schizophrenia consistently perform worse than healthy controls on the antisaccade task in which the subject is required to inhibit a reflexive saccade to a suddenly appearing visual target and look in the opposite direction. To our knowledge there is no research yet showing how patients at ultra high risk (UHR) for developing psychosis perform on the antisaccade task. The aim of the present study was to investigate antisaccade task performance in UHR patients. Patients were eligible for the study when they met criteria for one or more of the following groups: Attenuated symptoms or brief limited intermitted psychotic symptoms or a first-degree family member with a psychotic disorder and reduced functioning or basic symptoms. In 35 UHR patients we assessed antisaccades, neuropsychological test performance and symptomatology. Antisaccade task results were compared with those obtained in 42 age- and intelligence-matched patients with recent-onset schizophrenia and 28 matched healthy controls. Antisaccade error rate was significantly higher in the UHR patients than in the controls. Schizophrenia patients performed worse than the UHR patients and the control subjects. We found a trend towards higher antisaccade error rate at baseline in the UHR patients who later made the transition to psychosis compared to the UHR patients who did not make the transition to psychosis. Poor spatial working memory function was related to increased antisaccade errors in the UHR group. Abnormal antisaccade task performance is also present in patients at UHR for developing psychosis. Subsequent research needs to clarify if increased antisaccade error rate is predictive of a psychotic episode. In UHR patients, poor antisaccade performance may reflect working memory dysfunction.

Entities:  

Mesh:

Year:  2007        PMID: 17656071     DOI: 10.1016/j.schres.2007.06.022

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  25 in total

1.  Prefrontal function at presentation directly related to clinical outcome in people at ultrahigh risk of psychosis.

Authors:  P Fusar-Poli; M R Broome; P Matthiasson; J B Woolley; A Mechelli; L C Johns; P Tabraham; E Bramon; L Valmaggia; S C Williams; P McGuire
Journal:  Schizophr Bull       Date:  2009-08-07       Impact factor: 9.306

Review 2.  The prodrome and clinical risk for psychotic disorders.

Authors:  Sandra M Goulding; Carrie W Holtzman; Hanan D Trotman; Arthur T Ryan; Allison N Macdonald; Daniel I Shapiro; Joy L Brasfield; Elaine F Walker
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2013-06-18

Review 3.  Research in people with psychosis risk syndrome: a review of the current evidence and future directions.

Authors:  Christoph U Correll; Marta Hauser; Andrea M Auther; Barbara A Cornblatt
Journal:  J Child Psychol Psychiatry       Date:  2010-02-26       Impact factor: 8.982

4.  Antisaccade and prosaccade eye movements in individuals clinically at risk for psychosis: comparison with first-episode schizophrenia and prediction of conversion.

Authors:  Luca Kleineidam; Ingo Frommann; Stephan Ruhrmann; Joachim Klosterkötter; Anke Brockhaus-Dumke; Wolfgang Wölwer; Wolfgang Gaebel; Wolfgang Maier; Michael Wagner; Ulrich Ettinger
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-01-11       Impact factor: 5.270

5.  Robust differences in antisaccade performance exist between COGS schizophrenia cases and controls regardless of recruitment strategies.

Authors:  Allen D Radant; Steven P Millard; David L Braff; Monica E Calkins; Dorcas J Dobie; Robert Freedman; Michael F Green; Tiffany A Greenwood; Raquel E Gur; Ruben C Gur; Laura C Lazzeroni; Gregory A Light; Sean P Meichle; Keith H Nuechterlein; Ann Olincy; Larry J Seidman; Larry J Siever; Jeremy M Silverman; William S Stone; Neal R Swerdlow; Catherine A Sugar; Ming T Tsuang; Bruce I Turetsky; Debby W Tsuang
Journal:  Schizophr Res       Date:  2014-12-29       Impact factor: 4.939

Review 6.  The tell-tale tasks: a review of saccadic research in psychiatric patient populations.

Authors:  Diane C Gooding; Michele A Basso
Journal:  Brain Cogn       Date:  2008-10-23       Impact factor: 2.310

7.  Catechol-O-methyltransferase Val 158 Met polymorphism and antisaccade eye movements in schizophrenia.

Authors:  Haraldur Magnus Haraldsson; Ulrich Ettinger; Brynja B Magnusdottir; Thordur Sigmundsson; Engilbert Sigurdsson; Andres Ingason; Hannes Petursson
Journal:  Schizophr Bull       Date:  2008-06-17       Impact factor: 9.306

8.  Oculomotor and pupillometric indices of pro- and antisaccade performance in youth-onset psychosis and attention deficit/hyperactivity disorder.

Authors:  Canan Karatekin; Christopher Bingham; Tonya White
Journal:  Schizophr Bull       Date:  2009-05-08       Impact factor: 9.306

Review 9.  A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates.

Authors:  Sarel J Brand; Marisa Moller; Brian H Harvey
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

10.  Eye movement dysfunction in first-degree relatives of patients with schizophrenia: a meta-analytic evaluation of candidate endophenotypes.

Authors:  Monica E Calkins; William G Iacono; Deniz S Ones
Journal:  Brain Cogn       Date:  2008-10-18       Impact factor: 2.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.